FindTrial
Sign In

Comparison between two candidosis treatments in patients undergoing head and neck cancer through photodynamic therapy

Comparison between two photodynamic therapy protocols in the candidosis of patients undergoing treatment for head and neck cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5chx4n6
Enrollment
Unknown
Registered
2021-02-02
Start date
2019-06-20
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Candidosis.

Interventions

The sample calculation was based on service data and literature, a total of 120 patients will be evaluated between June 2019 and February 2021. Questionnaires will be applied for anamnesis, socioecono
E02.186.500

Sponsors

Univesrsidade Estadual de Montes Claros
Lead Sponsor
Univesrsidade Estadual de Montes Claros
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Individuals with confirmed histopathological diagnosis; CCECP treated exclusively with radiotherapy; or associated with chemotherapy and or; surgery at the Oncology Sector of Hospital Dilson de Quadros Godinho.

Exclusion criteria

Exclusion criteria: Exclusion criteria will be patients with histological diagnoses other than CCECP; or who have not agreed to participate in the research.

Design outcomes

Primary

MeasureTime frame
The primary outcome is the reduction and / or elimination of radiotherapy-induced candidosis in patients with head and neck cancer after treatment with photodynamic therapy. Clinical examination and PCR technique will be used to assess candidiasis. To determine whether there has been a reduction, patients treated with methylene blue aPDT (intervention) and curcumin aPDT treatment (control) will be compared.—

Countries

Brazil

Contacts

Public ContactAndre Guimaraes
andre.guimaraes@unimontes.br+55038988313705

Outcome results

None listed

Source: REBEC (via WHO ICTRP)